Log in to save to my catalogue
Log in to save to my catalogue

FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR...

| Ask | Become a Library member

FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2019_eular_4234

FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

About this item

Full title

FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Author / Creator

Merrill, Joan , June, Joshua , Koumpouras, Fotios , Machua, Wambui , Khan, Mohammad Faisal , Askanase, Anca , Khosroshahi, Arezou , Sheikh, Saira , James, Judith A. , Guthridge, Joel , Rathi, Gaurav , Burington, Bart , Foster, Paul and Zack, Debra

Journal title

Annals of the rheumatic diseases, 2019-06, Vol.78, p.761-762

Language

English

Formats

Articles

More information

Alternative Titles

Full title

FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1136_annrheumdis_2019_eular_4234

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2019_eular_4234

Other Identifiers

ISSN

0003-4967

DOI

10.1136/annrheumdis-2019-eular.4234

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections